Jon Root

Articulinx, Inc. develops minimally invasive implants for the treatment of osteo-arthritis. It offers minimally invasive implants and devices for chronic drug therapies, and orthopedics, The company was founded by Michael Hogendijk and Michael Orth in February 2007 and is headquartered in Cuppertino, CA.

Mission Bay Capital Management Inc (Mission Bay Capital) is a venture capital firm founded in 2009. The firm is headquartered in San Francisco, California.

Cleave Biosciences, Inc. engages in the development of cancer drug products. The company was founded by Raymond J. Deshaies, Seth Cohen, Francesco Parlati, Peter A. Thompson and Laura K. Shawver in 2010 and is headquartered in San Francisco, CA.

Omada Health, Inc. engages in the provision of digital health services. It offers online diabetes and obesity prevention programs, health coaching, and integration of web, mobile, and smart devices. The company was founded by Andrew DiMichele, Adrian James, and Sean Duffy in 2011 and is headquartered in San Francisco, CA.

Swoop.com, Inc. develops applications for online shopping. The company was founded by Ronald E. Elwell, Simeon Simeonov and John W. Hadl in 2011 and is headquartered in Cambridge, MA.

eFFECTOR Therapeutics Operations, Inc. discovers and develops translation regulators. It offers small molecule therapeutics that control gene expression for the treatment of cancer and other serious diseases. Its pipeline of translation regulators includes eFT508, eIF4E, and eIF4A. The company was founded by James R. Appleman, Kevin L. Eastwood, Siegfried Reich, Davide Ruggero, Kevan Shokat, and Stephen T. Worland in 2012 and is headquartered in San Diego, CA.

Inceptus Medical LLC (Inceptus Medical) is a venture capital firm founded in 2011 by Robert F. Rosenbluth, Paul Lubock and Brian Cox. The firm is headquartered in Aliso Viejo, California.

Ribon Therapeutics, Inc. operates as a biotechnology company which focuses on developing therapeutics targeting monoADP-ribosylating PARPs for cancer. Its medicines are used for blocking cancer cells? fundamental survival mechanisms. The company was founded by W. Lee Kraus, Tim Mitchison and Paul Chang in 2015 and is headquartered in Lexington, MA.

Silverback Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. It focuses on the proprietary ImmunoTAC technology platform to develop systemically delivered, tissue targeted therapeutics for the treatment of cancer, chronic viral infections, and other serious diseases. The company was founded by Peter A. Thompson January 4, 2016 and is headquartered in Seattle, WA.

Route 92 Medical, Inc. engages in the provision of healthcare services. The company was founded by Tony M. Chou and Scott Wilson in 2015 and is headquartered in San Mateo, CA.

Okami Medical, Inc. operates as a development stage company which focuses on advancement of interventional devices and therapies in cardiovascular markets. The company was founded by Robert F. Rosenbluth in 2014 and is headquartered in Aliso Viejo, CA.

HealthJoy LLC engages in the development of technology platform to provide healthcare services. Its product enables the patients to consult for medication and make healthcare decisions online; and also delivers medical results to patients. The company was founded by Justin Holland and Doug Morse-Schindler in 2014 and is headquartered in Chicago, IL.

Part of New York Hospital, Weill Cornell Medical Center provides healthcare services. The company is based in New York.

Carlsmed, Inc. develops AI based technology solutions to the medical industry. Its solutions are utilized as an information database for surgeons using traditional surgical techniques. The company was founded by Mike Cordonnier and Niall Casey and is headquartered in La Jolla, CA.

Valeritas, Inc. engages in the development and commercialization of drug delivery solutions for the treatment of diabetes. Its product, V-Go wearable insulin delivery device, which enables patients to closely mimic the body’s normal physiologic pattern of insulin delivery by using one type of insulin at a continuous preset basal rate over a 24-hour period and provides on-demand bolus dosing for meals and snacks. The company was founded on August 2, 2006 and is headquartered in Bridgewater, NJ.